Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-10-10

Clinical Trial Update: Measurement of Urinary Catabolites of PACs as Biomarkers of Consumption of Cranberry Extracts [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating urinary catabolites of proanthocyanidins as biomarkers of cranberry extract consumption in individuals with urinary tract in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cranberry extract (Cranberry extract)

Snippet

Sponsor: Laval University | Conditions: Urinary Tract Infections | Phase 1 | Status: COMPLETED